Related Experiment Video
Updated: Aug 28, 2025
10:37
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
8.4K
Circulating microRNAs in Hidradenitis Suppurativa
Bruna De Felice1, Concetta Montanino1, Marta Mallardo1,2
1Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DISTABIF), University of Campania Luigi Vanvitelli, Via Vivaldi 43, 81100 Caserta, Italy.
Genes
|September 23, 2022
Summary
MicroRNAs (miRNAs) show altered expression in hidradenitis suppurativa (HS) patients. Specific miRNA profiles, like miR-338-5p, may aid in early HS diagnosis and understanding disease progression.
Area of Science:
- Dermatology
- Molecular Biology
- Immunology
Background:
- Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition with unclear molecular inflammatory pathways.
- MicroRNAs (miRNAs) are known regulators of inflammatory and immune responses.
- Understanding miRNA involvement in HS pathogenesis is crucial for developing diagnostic and therapeutic strategies.
Purpose of the Study:
- To analyze the micro-transcriptome RNA library in the blood of HS patients.
- To identify specific microRNA (miRNA) expression profiles associated with HS.
- To explore the potential of miRNAs as early diagnostic biomarkers for HS.
Main Methods:
- Analysis of total miRNA expression profiles using real-time quantitative polymerase chain reaction (qPCR).
- Comparison of miRNA expression between HS patients and healthy controls.
- Identification of significantly differentially expressed miRNAs.
Main Results:
- Significant differences in the expression of miR-24-1-5p, miR-146a-5p, miR26a-5p, miR-206, miR338-3p, and miR-338-5p were observed in HS patients compared to controls.
- miR-338-5p was found to be atypically overexpressed and closely related to HS invasiveness and cytokine production.
Conclusions:
- miRNA expression profiles in HS patients offer insights into disease pathogenesis.
- Specific miRNAs, particularly miR-338-5p, show potential as non-invasive biomarkers for early HS diagnosis.
- Further research into miRNA mechanisms can advance HS management and treatment.
